Lenvatinib Mesylate and Tetracycline (class) Oral, Parenteral
Determining the interaction of Lenvatinib Mesylate and Tetracycline (class) Oral, Parenteral and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: tetracycline
Brand name: Ala-Tet, Brodspec, Panmycin, Sumycin, Tetracap, Tetracon, Robitet 500, Emtet-500
Synonyms: Tetracycline, Tetracycline (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Tetracycline (Systemic)
- Lenvatinib Mesylate-Tetracycline Hydrochloride
- Lenvatinib Mesylate-Tetracycline Mucous membrane, oral
- Lenvatinib Mesylate-Tetracycline Topical application
- Lenvatinib Mesylate-Tetrahydrozoline (Nasal)
- Lenvatinib Mesylate-Tetrahydrozoline and zinc ophthalmic
- Tetracycline (class) Oral, Parenteral-Lenvima
- Tetracycline (class) Oral, Parenteral-Lenvima (14 MG Daily Dose)
- Tetracycline (class) Oral, Parenteral-Lenvima (18 MG Daily Dose)
- Tetracycline (class) Oral, Parenteral-Lenvima (20 MG Daily Dose)
- Tetracycline (class) Oral, Parenteral-Lenvima (24 MG Daily Dose)
- Tetracycline (class) Oral, Parenteral-Lenvima (8 MG Daily Dose)